BioPharmica Limited - July 2
Proposed code: BPH
Issue price: $0.20
Principal activities: Biomedical commercialisation business partnering univerisities, medical institutes, companies and hospitals.
Corporate: David Breeze (chairman and managing director); Seng Yap (non-executive director); and Charles Murphy (executive director).
www.biopharmica.com.au
(08) 9244 9631
BioPharmica plans to raise $4.5 million from a 20 cent a share offer that is scheduled to close on June 25. The offer is not underwritten.
